Physicians Seek Unrestricted Coverage Of NaF-18 PET For Bone Metastasis
This article was originally published in The Gray Sheet
Executive Summary
Recent shortages of an isotope commonly used in bone scans have prompted several professional societies to urge CMS to offer cancer patients broad access to sodium fluoride-18 positron emission tomography to identify bone metastasis
You may also be interested in...
CMS Proposes Coverage With Study Participation For PET In Bone Metastasis
CMS is proposing to cover positron emission tomography imaging for identification of bone metastasis in patients with a previously diagnosed solid tumor, but only as part of prospective clinical trials, the agency announced Nov. 30
Oncology PET Scan Coverage Expands As CMS Lifts Some Data Mandates
Medicare coverage of PET scans for oncology indications will be less restrictive under a national coverage determination finalized April 3
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.